Results 81 to 90 of about 243 (91)

MLC901 in post stroke recovery in the eastern European population: A preliminary result of a multicentre study

Journal of the Neurological Sciences, 2019
A. Arsovska, J. Opara
semanticscholar   +2 more sources

MLC901, a Traditional Chinese Medicine protects the brain against global ischemia

Neuropharmacology, 2011
Global ischemia leads to damage in the hippocampal CA1 region and is associated with behavioral deficits. NeuroAid (MLC601 and MLC901), a Traditional Chinese Medicine is used in China for patients after stroke. We have investigated here the effects of MLC901 on brain injury and deficits after global ischemia in the rat.
H, Quintard, M, Borsotto, J, Veyssiere, C, Gandin, F, Labbal, C, Widmann, M, Lazdunski, C, Heurteaux   +7 more
openaire   +2 more sources

Neuroprotective and neuroproliferative activities of NeuroAid (MLC601, MLC901), a Chinese medicine, in vitro and in vivo

Neuropharmacology, 2010
Although stroke remains a leading cause of death and adult disability, numerous recent failures in clinical stroke trials have led to some pessimism in the field. Interestingly, NeuroAid (MLC601), a traditional medicine, particularly used in China, South East Asia and Middle East has been reported to have beneficial effects in patients, particularly in
Heurteaux, C., Gandin, C., Borsotto, M., Widmann, C., Brau, F., Lhuillier, M., Onteniente, Brigitte, Lazdunski, Michel   +7 more
openaire   +3 more sources

The effect of MLC901 therapy on neutrophil-to-lymphocyte-ratio, platelet-to-lymphocyte-ratio, BDNF, MoCA-INA score, and Barthel-index score in traumatic brain injury patients

Bali Medical Journal
Background: An intervention is needed to prevent secondary-brain-injury (SBI) post-traumatic-brain-injury (TBI) and improved the patient’s clinical outcome.
G. F. Kusuma, Sri Maliawan, T. Mahadewa, Ni Nyoman Sri Budayanti, T. Senapathi, A. Laksmidewi   +5 more
semanticscholar   +1 more source

Activation of ATP-sensitive potassium channels as an element of the neuroprotective effects of the Traditional Chinese Medicine MLC901 against oxygen glucose deprivation

Neuropharmacology, 2012
NeuroAid (MLC601 and MLC901), a Traditional Medicine used in China for patients after stroke has been reported in preclinical models of ischemia to induce neuroprotection and neuroplasticity. This work shows the effects of MLC901 on an in vitro model of oxygen glucose deprivation (OGD).
H, Moha Ou Maati, M, Borsotto, F, Chatelain, C, Widmann, M, Lazdunski, C, Heurteaux   +5 more
openaire   +2 more sources

The Effect of NeuroAid (MLC901) on Cholestasis-Induced Spatial Memory Impairment with Respect to the Expression of BAX, BCL-2, BAD, PGC-1α and TFAM Genes in the Hippocampus of Male Wistar Rats

Neurochemical Research, 2021
Pejman Molaei, Salar Vaseghi, M. Entezari, M. Hashemi, M. Nasehi   +4 more
semanticscholar   +1 more source

P2‐032: Effects of Neuroaid II (MLC901) on App Processing and TAU Phosphorylation

Alzheimer's & Dementia, 2016
Wei Thye Lee Lee, Christopher Chen, Yun-An Lim   +2 more
openaire   +1 more source

Use of MLC901 in cognitive impairment after stroke

Journal of Neurological Sciences
A. Arsovska
semanticscholar   +1 more source

MLC601/MLC901, issu de la médecine chinoise induit de puissantes propriétés neuroprotectrices et neurorégénératives face à l’ischémie cérébrale chez le rongeur

Revue Neurologique, 2012
Hervé Quintard, Marc Borsotto, Catherine Widmann, Carine Gandin, Michel Lazdunski, Catherine Heurteaux   +5 more
openaire   +1 more source

THE NEUROAID II (MLC901) IN VASCULAR COGNITIVE IMPAIRMENT STUDY (NEURITES): BASELINE RESULTS

2018
openaire   +1 more source